US Patent 8569227 Stabilized fibronectin domain compositions, methods and uses

Patent 8569227 was granted and assigned to Janssen Biotech on October, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Janssen Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8569227

Date of Patent

October 29, 2013

Patent Application Number

13097587

Date Filed

April 29, 2011

Patent Citations Received

‌

US Patent 11802269 Superpiggybac transposase compositions

‌

US Patent 11833190 Serum albumin-binding fibronectin type III domains

‌

US Patent 11932680 CD8A-binding fibronectin type III domains

‌

US Patent 11781138 FN3 domain-siRNA conjugates and uses thereof

Patent Primary Examiner

‌

Christina Bradley

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8569227 Stabilized fibronectin domain compositions, methods and uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API